Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

CDC director says boosters needed to protect workers

Published 09/24/2021, 01:12 PM
Updated 09/24/2021, 06:06 PM
© Reuters. FILE PHOTO: Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), and top infectious disease expert Dr. Anthony Fauci, testify before the Senate Health, Education, Labor, and Pensions Committee on Capitol hill in Washing

By Ahmed Aboulenein and Michael Erman

WASHINGTON (Reuters) -U.S. Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky on Friday said she recommended booster shots for at-risk adult workers to protect essential workers and minority communities despite the agency's advisory committee voting against the measure.

The U.S. government is rolling out boosters starting with third doses of the Pfizer/BioNTech vaccine for Americans aged 65 and older, adults with underlying medical conditions and those in high-risk working and institutional settings, after health regulators cleared the move this week and Walensky signed off https://www.reuters.com/world/us/us-cdc-advisers-recommend-covid-19-vaccine-boosters-65-older-high-risk-2021-09-23 on it earlier on Friday.

"Many of our frontline workers, essential workers, and those in congregate settings, come from communities that have already been hardest hit," Walensky told reporters. "It was a decision about providing rather than withholding access."

Walensky's decision broke from a recommendation on Thursday by a group of expert outside advisors who felt that a narrower group of people should initially receive the extra shot. She is not obliged to follow the advice of the panel.

"This was a scientific close call. In that situation, it was my call to make," she said at a White House briefing.

© Reuters. FILE PHOTO: Rochelle Walensky, Director of the Centers for Disease Control and Prevention, looks on prior to a Senate Health, Education, Labor, and Pensions Committee hearing on Capitol hill in Washington, D.C., U.S., July 20, 2021. Stefani Reynolds/Pool via REUTERS/File Photo

Walensky said the CDC would update its guidance on boosters as needed and expects to evaluate in the coming weeks data on boosters for recipients of the Moderna (NASDAQ:MRNA) and Johnson & Johnson (NYSE:JNJ) COVID-19 vaccines.

White House coronavirus response coordinator Jeff Zients, who was also at the briefing said: "We are ready and we are prepared and implementation is happening as we speak. So there are people who will be getting booster shots as early as this afternoon."

Latest comments

The FDA a few weeks ago overwhelmingly against a booster but the Faucian CDC doesn't trust the science all of a sudden which only proves they make it up as they go.
1 shot 2 shots 3 shots fk 🤡🤡🤡
Peddling fear and propaganda
I seem to be in good company in this thread lol
boost your as£$$$$
CDC Director made political anti science decision: “Walensky's decision broke from a recommendation on Thursday by a group of expert outside advisors who felt that a narrower group of people should initially receive the extra shot”
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.